These final results, together with a earlier report exhibiting that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like habits in mice,2 support the strategy of targeting ACKR3 as a unique way to modulate the opioid process, which could open new therapeutic avenues for opioid-related disorders.Often I obtain a slight agony inside a joint